Examining within-country variation of maternity costs in the context of a multicountry, multicentre randomised controlled trial

Applied Health Economics and Health Policy

Volumn 3, Issue 3, 2004, Pages 161-170

  Hutton, Guy ^a   Fox Rushby, Julia ^b   Mugford, Miranda ^c   Thinkhamrop, Jadsada ^d   Thinkhamrop, Bandit ^d   Galvez, Ana Maria ^e   Alvarez, Manuel ^e  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d KHON KAEN UNIVERSITY   (Thailand)

^e MINISTERIO DE SALUD PÚBLICA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CUBA; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH SERVICE; MATERNAL CARE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PRENATAL CARE; THAILAND;

AMBULATORY CARE; COSTS AND COST ANALYSIS; CUBA; FEMALE; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; MULTICENTER STUDIES AS TOPIC; PREGNANCY; PRENATAL CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THAILAND;

EID: 21744435585     PISSN: 11755652     EISSN: 11755652     Source Type: Journal    
DOI: 10.2165/00148365-200403030-00007     Document Type: Article

References (38)

1. Spath HM, Carrere MO, Fervers B, et al. Analysis of the eligibility of published economic evaluations for transfer to a given health care system: methodological approach and application to the French health care system. Health Policy 1999; 49: 161-77
2. Madden L, Hussey R, Mooney G, et al. Public health and economics in tandem: programme budgeting, marginal analysis and priority setting in practice. Health Policy 1995; 33: 161-8
3. Drummond MF, Bloom BS, Carrin G, et al. Issues in the cross-national assessment of health technology. Int J Technol Assess Health Care 1992; 8: 671-82
4. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95-104
5. Jefferson T, Mugford M, Graym A, et al. An exercise on the feasibility of carrying out secondary economic analyses. Health Econ 1996; 5: 155-65
6. O'Brien B. A tale of two (or more) cities: geographical transferability of pharmacoeconomic data. Am J Manag Care 1997; 3 Suppl.: S33-9
7. Bryan S, Brown J. Extrapolation of cost-effectiveness information to local settings. J Health Serv Res Policy 1998; 3: 108-12
8. Udvarhelyi IS, Colditz GA, Rai A, et al. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med 1992; 116: 238-44
9. Gerard K, Mooney G. QALY league tables: handle with care. Health Econ 1993; 2: 59-64
10. Mason J, Drummond M. Reporting guidelines for economic studies. Health Econ 1995; 4: 85-94
11. Walker D, Fox-Rushby JA. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Econ 2000; 9: 681-98
12. Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6: 217-27
13. Heyse J, Cook J, Carides G. Statistical considerations in analysing health care resource utilization and cost data. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001
14. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001
15. Drummond M, Pang F. Transferability of economic evaluation results. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001
16. De Jonghe E, Murray C, Chum H, et al. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania. Int J Health Plann Manage 1994; 9: 151-81
17. Schulman K, Buxton M, Glick H, et al. Results of the economic evaluation of the FIRST study: a multinational prospective economic evaluation. FIRST Investigators: Flolan International Randomized Survival Trial. Int J Technol Assess Health Care 1996; 12: 698-713
18. Menzin J, Oster G, Davies L, et al. A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis. Int J Technol Assess Health Care 1996; 12: 52-61
19. Villar J, Ba'aqeel H, Piaggio G, et al. WHO antenatal care randomised controled trial for the evaluation of a new model of routine antenatal care trial. Lancet 2001; 357: 1551-64
20. Schulman K, Burke J, Drummond M, et al. Resource costing for multinational neurologic clinical trials: methods and results. Health Econ 1998; 7: 629-38
21. Jonsson B, Johannesson M, Kjekshus J, et al. Cost-effectiveness of cholesterol lowering: results from the Scandinavian simvastatin survival study (4S). Eur Heart J 1996; 17: 1001-7
22. Glick H, Willke R, Polsky D, et al. Economic analysis of Tirilazad Mesylate for aneurysmal subarachnoid hemorrhage. Int J Health Plann Manage 1998; 14: 145-60
23. Dasbach E, Rich M, Segal R, et al. The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure. Cardiology 1999; 91: 189-94
24. Jonsson B, Weinstein M. Economic evaluation alongside multinational trials: study considerations for GUSTO IIb. Int J Technol Assess Health Care 1997; 13: 49-58
25. Wimo A, Winblad B, Engedal K, et al. An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial. Dement Geriatr Cogn Disord 2003; 15: 44-54
26. Lumbiganon P, Bergso P, Ba'aqeel H, et al., editors. A randomised controlled trial for the evaluation of a new antenatal care model. Paediatr Perinat Epidemiol 1998; 12 Suppl. 2: 1-164
27. Mugford M, Hutton G, Fox-Rushby J. Methods for the economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO antenatal care randomised controlled trial. Paediatr Perinat Epidemiol 1998; 12: 75-97
28. Donaldson C. The state of the art of costing health care for economic evaluation. Community Health Stud 1990; 14: 341-56
29. Rovira J. Standardising economic appraisal of health technology in the European Community. Soc Sci Med 1994; 38: 1675-8
30. Baladi J-F. A guidance process for the costing process. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 1996
31. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
32. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. New York: Oxford University Press, 1997
33. Galvez A, Alvarez M, Sanabria G, et al. Economic evaluation alongside an antenatal care trial in developing countries. Report on Cuba [research report no. 12]. Norwich: School of Health Policy and Practice, University of East Anglia, 2000
34. Thinkhamrop J, Thinkhamrop B, Kuchaisit C, et al. A study on the costs of antenatal care alongside the World Health Organization trial in Thailand [research report no. 10]. Norwich: School of Health Policy and Practice, University of East Anglia, 2000
35. Borghi J, Bastus S, Belizan M, et al. Costs of antenatal and related care in Argentina: a cost-minimisation analysis of the new WHO antenatal care package. London: London School of Hygiene and Tropical Medicine, 2000
36. Smith S, Fox-Rushby J, Hutton G, et al. An economic evaluation of the costs of the new WHO programme of antenatal care in Saudi Arabia. London: London School of Hygiene and Tropical Medicine, 2001
37. Langer A, Villar J, Romero M, et al. Are women and providers satisfied with antenatal care? Views on a standard and a simplified, evidence-based model of care in four developing countries. BMC Womens Health 2002; 2: 7-16
38. Langer A, Nigenda G. Conceptual basis and methodology for the evaluation of women's and providers' perception of the quality of antenatal care in the WHO antenatal care randomised controlled trial. Paediatr Perinat Epidemiol 1998; 12: 98-115